Analysis AbbVie Inc. (0QCV)
6/2/2024
Analysis of AbbVie Inc. (0QCV)
AbbVie Inc. is a pharmaceutical company that has been performing well recently. Looking at the provided data, we can see that the stock price has been fluctuating around the $160 mark in the past few days. The Relative Strength Index (RSI) values indicate that the stock is currently in the oversold territory, with values ranging from 29.39 to 53.86.The Moving Average Convergence Divergence (MACD) indicator shows negative values, indicating a bearish trend in the stock price. However, the MACD histogram has been showing some positive values, suggesting a possible reversal in the trend.
Overall, AbbVie Inc. seems to be facing some selling pressure, as indicated by the RSI values and the MACD indicator. Investors should closely monitor the stock price for any potential changes in trend direction.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This indicates growth compared to the EPS of $5.67 from the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This forecast suggests a slight increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and the next fiscal years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 9.7%.
Overall, it appears that the company has experienced a significant growth rate in the past but is expected to see a more moderate growth rate in the coming years, with a slight increase in the next year compared to the current year.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin is 26.306%.
- Fiscal year ends on September 30, 2023.
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin is 30.743%.
- Most recent quarter is March 31, 2024.
- Return on assets TTM is 22.073999% and return on equity TTM is 147.25%.
Stock statistics:
- Short ratio is 1.53.
- Float shares are 15,308,320,742.
- Shares short are 99,287,450.
- Average 10-day volume is 46,860,048.
- Average 90-day volume is 57,498,254.
- Shares outstanding are 15,334,099,968.
- Percent held by insiders is 5.22% and percent held by institutions is 57.589%.
- Short percent of shares outstanding is 0.65%.
Valuation metrics:
- PEG ratio is 26.319502.
- Forward PE is 26.319502.
- Trailing PE is 29.59409.
- Enterprise value is $2,950,762,332,160.
- Price to book MRQ is 39.3405.
- Price to sales TTM is 7.646095.
- Enterprise to EBITDA is 22.763.
- Enterprise to revenue is 7.732.
- Market capitalization is $2,917,925,650,432.
Stock price summary:
- Beta is 1.264.
- 50-day moving average is $176.2646.
- 200-day moving average is $181.0429.
- Fifty-two week low is $164.08.
- Fifty-two week high is $199.62.
- Fifty-two week change is 6.853%.
Dividends and splits:
- Payout ratio is 14.93%.
- Dividend date is May 16, 2024.
- Last split date is August 31, 2020.
- Ex-dividend date is May 10, 2024.
- Last split factor is a 4-for-1 split.
- Forward annual dividend rate is $1.
- 5-year average dividend yield is 0.73%.
- Forward annual dividend yield is 0.5255%.
- Trailing annual dividend rate is $0.97.
- Trailing annual dividend yield is 0.5097%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe that the company has experienced a steady increase in revenue from 2020 to 2022, with a slight decrease in 2023. This trend indicates a generally positive growth trajectory for the company over the past few years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities have a significant impact on the company's cash position, with large amounts being used for common stock repurchase and debt issuance.
4. Investing activities show a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow impact each year.
5. Interest paid and income tax paid figures provide insights into the company's financial obligations and profitability trends over the years.
6. The end cash position has been fluctuating, reflecting the company's cash management strategies and financial performance.
MACD of 0QCV
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
